Advertisement
Original article| Volume 22, ISSUE 1, P35-40, January 01, 2000

Download started.

Ok

Phenytoin administration in the newborn and infant

      Abstract

      To evaluate the efficacy and safety of phenytoin (PHT) in the treatment of situation-related seizures and epilepsies in the newborn and infant; the clinical histories of 82 patients were retrospectively reviewed. Sixty patients received for status epilepticus (SE), intravenous PHT followed by long-term oral administration for 27 of them. The other 22 patients had oral treatment only. Intravenous administration made 55% of these patients seizure-free, whereas oral administration produced lasting seizure control in only 9.1%. During chronic oral treatment, it was most difficult to obtain adequate plasma concentrations in 69.1% of the patients, and 43.6% had side effects, most of which were related to very high plasma concentrations. In conclusion, in the first 2 years of life, intravenous administration of PHT is useful for SE, but oral treatment is poorly effective with difficulty to achieve appropriate and stable therapeutic plasma concentrations, and with frequent side effects.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bourgeois B.F.
        Antiepileptic drugs.
        in: Wallace S.J. Epilepsy in children. Chapman and Hall, London1996: 536-537
        • Mattson R.H.
        • Cramer J.A.
        • Collins J.F.
        • Smith D.B.
        • Delgado-Escueta A.V.
        • Brown T.R.
        • et al.
        Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures.
        New Engl J Med. 1985; 313: 145-151
        • Richard M.O.
        • Chiron C.
        • d'Athis P.
        • Rey E.
        • Aubourg P.
        • Dulac O.
        • et al.
        Phenytoin monitoring in status epilepticus in infants and children.
        Epilepsia. 1993; 34: 144-150
        • Painter M.J.
        • Gaus L.M.
        Neonatal seizures:diagnosis and treatment.
        J Child Neurol. 1991; 6: 101-108
        • Painter M.J.
        • Pippenger C.
        • Wasterlain C.
        • Barmada M.
        • Pitlick W.
        • Carter G.
        • et al.
        Phenobarbital and phenytoin in neonatal seizures: metabolism and tissue distribution.
        Neurology. 1981; 31: 1107-1112
        • Bourgeois B.F.
        • Dodson W.E.
        Phenytoin elimination in newborns.
        Neurology. 1983; 33: 173-178
        • Painter M.J.
        • Pippenger C.
        • MacDonald H.
        • Pitlick W.
        Phenobarbital and diphenylhydantoin levels in neonates with seizures.
        J Pediatr. 1978; 92: 315-319
        • Leff R.D.
        • Fischer L.J.
        • Roberts R.J.
        Phenytoin metabolism in infants following intravenous and oral administration.
        Dev Pharmacol Ther. 1986; 9: 217-223
        • Loughnan P.M.
        • Greenwald A.
        • Purton W.
        • Aranda J.V.
        • Watters G.
        • Neims A.H.
        Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.
        Arch Dis Child. 1977; 52: 302-309
        • Finn A.L.
        • Olanow C.W.
        Taylor W.J. Finn A.L. Individualizing drug therapy:practical applications of drug monitoring Vol II. Gross-Townsend-Frank, New York1989: 63-85
        • Dodson W.E.
        Phenytoin elimination in childhood:effect of concentration-dependent kinetics.
        Neurology. 1980; 3: 196-199
      1. Commission on Classification and Terminology of the International League against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.

        • Aicardi J.
        Epilepsy in children. Raven Press, New York1986
        • Scher M.S.
        • Hamid M.Y.
        • Steppe D.A.
        • Beggarly M.E.
        • Painter M.J.
        Ictal and interictal electrographic seizure duration in preterm and term neonates.
        Epilepsia. 1993; 34: 284-288
        • Dulac O.
        • Aubourg P.
        • Checoury A.
        • Devictor A.
        • Plouin P.
        • Arthuis M.
        Etats de mal convulsifs du nourrisson. Aspects sémiologiques, étiologiques et pronostiques.
        Rev EEG Neurophysiol Clin. 1985; 14: 255-262
        • Nabbout R.c.
        • Chiron C.
        • Mumford J.
        • Dumas C.
        • Dulac O.
        Vigabatrin in partial seizures in children.
        J Child Neurol. 1997; 12: 172-177
        • Perez J.
        • Chiron C.
        • Musial C.
        • Rey E.
        • Blehaut H.
        • d'Athis P.
        • et al.
        Stiripentol: efficacy and tolerability in epileptic children.
        Epilepsia. 1999;
        • Brodtkorb E.
        • Aamo T.
        • Henriksen O.
        • Lossius R.
        Rectal diazepam: pitfalls of excessive use in refractory epilepsy in patients.
        Epilepsy Res. 1999; 35: 123-134
        • Plaa G.L.
        Acute toxicity of antiepileptic drugs.
        Epilepsia. 1975; 16: 183-191
        • Reynolds E.H.
        Phenytoin:toxicity.
        in: Levy R. Mattson R.H. Meldrum B. Penry J.K. Drefuss F.E. Antiepileptic drugs. 3rd ed. Raven Press, New York1989: 241-255
        • Schmidt D.
        Adverse effects of antiepileptic drugs. Raven Press, New York1982
        • Aman M.G.
        • Werry J.S.
        • Paxton J.W.
        • Turbott S.H.
        Effects of phenytoin on cognitive-motor performance in children as a function of drug concentration, seizure type, and time of medication.
        Epilepsia. 1994; 35: 172-180
        • Levy L.L.
        • Fenichel G.M.
        Diphenylhydantoin-activated seizures.
        Neurology. 1965; 15: 716-722
        • Vozeh S.
        • Uematsu T.
        • Aarons L.
        • Maitre P.
        • Landolt H.
        • Gratzl O.
        Intravenous phenytoin loading in patients after neurosurgery and in status epilepticus. A population pharmacokinetic study.
        Clin Pharmacokinet. 1988; 14: 122-128
        • Hellström-Westas L.
        • Blennow G.
        • Lindroth M.
        • Rosen I.
        • Svenningson N.W.
        Low risk of seizure recurrence after early withdraw of antiepileptic treatment in the neonatal periods.
        Arch Dis Child Fetal Neonatal Ed. 1995; 72: F97-F101